SeaStar Medical Secures $3.3M via Warrant Inducement, Issues 1.7M New Warrants
ICU sits 71% above its 52-week low of $2.07 on elevated volume (7.9× avg).
Summary
SeaStar Medical raised $3.3M by inducing early warrant exercise at a reduced price, issuing 1.7M new warrants in return. The financing extends runway but adds substantial potential dilution.
Key Events · Financing and Capital Events · ICU
-
Warrant Inducement Exercise
Holders exercised 854,002 existing warrants at a reduced price of $3.866 per share, generating approximately $3.3 million in gross proceeds.
-
New Warrants Issued
The company issued 1,708,004 new warrants at $3.616 per share — 854,002 Series A (5-year term) and 854,002 Series B (18-month term) — creating future dilution overhang.
-
Placement Agent Compensation
H.C. Wainwright received a 7% cash fee plus 1% management fee, $75,000 non-accountable expenses, $15,950 clearing fee, and 59,780 warrants at $4.8325 per share.
-
Financing Restrictions
The company agreed to a 30-day lock-up on new issuances and a 6-month prohibition on Variable Rate Transactions, limiting near-term financing flexibility.
Analysis · ICU · Industrial Applications And Services
To raise immediate capital, SeaStar Medical persuaded holders of 854,002 existing warrants to exercise early at a reduced price of $3.866 per share, yielding approximately $3.3 million in gross proceeds. In return, the company issued 1,708,004 new warrants at $3.616 per share — a structure that provides near-term cash but creates a significant future dilution overhang. The transaction unfolds against a backdrop of going-concern doubt raised in the Q2 10-Q, making this a survival capital raise with meaningful equity cost.
How filings like this one have moved
In the 30 days to Oct 19, 2026, 29.4% of the 1386 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.50%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, ICU was trading at $3.54 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $15.6M. The 52-week trading range was $2.07 to $7.35. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.